Clinical Trials Browser

Disease Progression × 30 days × Clear all

Colonic Neoplasms, Pancreatic Neoplasms, Disease Progression

NCT03259867 2026-04-16

TATE-PD1

Phase 2 Recruiting

54 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Stomach Neoplasms, Disease Progression

NCT07529626 2026-04-14

MIND-PANC

Not yet recruiting

320 enrolled

Gastrointestinal

Pancreatic cancer, adult, Anxiety Disorders, Depression, Pancreatic Neoplasms, Disease Progression

NCT07529639 2026-04-14

Tumor Budding and T1 Substaging in Urothelial Bladder Cancer

Not yet recruiting

100 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Disease Progression

NCT07514455 2026-04-07

RECOMEND

Phase 2 Not yet recruiting

20 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Disease Progression

NCT01191060 2026-04-06

IFM/DFCI2009

Phase 3 Completed

700 enrolled

Plasma cell

Disease Progression, Neoplasms, Plasma Cell

NCT07498413 2026-04-01

ROTOR

Completed

218,677 enrolled

Breast

Breast Neoplasms, Disease Progression

NCT04692675 2026-03-27

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

Phase NA Recruiting

508 enrolled

Genitourinary

Prostatic Neoplasms, Disease Progression

NCT06635447 2026-03-27

CAPItrue

Phase 3 Active not recruiting

258 enrolled

Breast

Breast Neoplasms, Disease Progression

Clinical Trials

Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

TATE-PD1

MIND-PANC

Tumor Budding and T1 Substaging in Urothelial Bladder Cancer

RECOMEND

IFM/DFCI2009

ROTOR

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

CAPItrue